India · Delayed Price · Currency is INR Cohance Lifesciences Statistics
Total Valuation
BOM:543064 has a market cap or net worth of INR 336.89 billion. The enterprise value is 338.32 billion.
| Market Cap | 336.89B |
| Enterprise Value | 338.32B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 382.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.94% |
| Shares Change (QoQ) | +45.67% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 229.46M |
Valuation Ratios
The trailing PE ratio is 139.57 and the forward PE ratio is 52.54.
| PE Ratio | 139.57 |
| Forward PE | 52.54 |
| PS Ratio | 26.76 |
| PB Ratio | 18.30 |
| P/TBV Ratio | 34.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 140.16 |
| EV / Sales | 26.88 |
| EV / EBITDA | 95.39 |
| EV / EBIT | 124.95 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | n/a |
| Interest Coverage | 21.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.99% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 10.55M |
| Profits Per Employee | 2.02M |
| Employee Count | 1,193 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543064 has paid 678.50 million in taxes.
| Income Tax | 678.50M |
| Effective Tax Rate | 22.34% |
Stock Price Statistics
The stock price has decreased by -17.24% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.24% |
| 50-Day Moving Average | 980.56 |
| 200-Day Moving Average | 1,099.72 |
| Relative Strength Index (RSI) | 33.64 |
| Average Volume (20 Days) | 8,999 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543064 had revenue of INR 12.59 billion and earned 2.41 billion in profits. Earnings per share was 9.40.
| Revenue | 12.59B |
| Gross Profit | 9.60B |
| Operating Income | 2.71B |
| Pretax Income | 3.04B |
| Net Income | 2.41B |
| EBITDA | 3.55B |
| EBIT | 2.71B |
| Earnings Per Share (EPS) | 9.40 |
Balance Sheet
The company has 2.80 billion in cash and 2.79 billion in debt, giving a net cash position of 13.40 million.
| Cash & Cash Equivalents | 2.80B |
| Total Debt | 2.79B |
| Net Cash | 13.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.41B |
| Book Value Per Share | 66.64 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.23%, with operating and profit margins of 21.51% and 19.18%.
| Gross Margin | 76.23% |
| Operating Margin | 21.51% |
| Pretax Margin | 24.12% |
| Profit Margin | 19.18% |
| EBITDA Margin | 28.18% |
| EBIT Margin | 21.51% |
| FCF Margin | n/a |
Dividends & Yields
BOM:543064 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.94% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.72% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Sep 25, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |